vonoprazan fumarate

FDA Drug Profile — VOQUEZNA

vonoprazan fumarate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including VOQUEZNA. Available dosage form: tablet.

Drug details

Generic Name
vonoprazan fumarate
Brand Names
VOQUEZNA
Application Number
NDA215151
Sponsor
Phathom Pharmaceuticals Inc.
NDC Codes
4
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
VONOPRAZAN FUMARATE

Indications and Usage

1 INDICATIONS AND USAGE VOQUEZNA is indicated: for healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. for the relief of heartburn associated with non-erosive gastroesophageal reflux disease in adults. in combination with amoxicillin and clarithromycin for the treatment of Helicobacter pylori ( H. pylori ) infection in adults. in combination with amoxicillin for the treatment of H. pylori infection in adults. VOQUEZNA is a potassium-competitive acid blocker indicated: for healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. ( 1 ) to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. ( 1 ) for the relief of heartburn associated with non-erosive gastroesophageal reflux disease in adults. ( 1 ) in combination with amoxicillin and clarithromycin for the treatment of Helicobacter pylori (H. pylori) infection in adults. ( 1 ) in combination with amoxicillin for the treatment of H. pylori infection in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.